Bristol-Myers Squibb Company
CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-- YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE

Last updated:

Abstract:

Disclosed is crystalline Form E of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-- yl)phenyl) amino)-N-(methyl-d.sub.3)pyridazine-3-carboxamide. Form E is a neat crystalline form. Characterization data for Form E are disclosed.

Status:
Application
Type:

Utility

Filling date:

28 Jan 2022

Issue date:

18 Aug 2022